DOI:
10.1039/C3DT53636J
(Paper)
Dalton Trans., 2014,
43, 9704-9713
Bioinspired manganese(II) complexes with a clickable ligand for immobilisation on a solid support†
Received
26th December 2013
, Accepted 17th April 2014
First published on 17th April 2014
Abstract
Clickable ligands like N,N′-bis((pyridin-2-yl)methyl)prop-2-yn-1-amine (L1) and N-((1-methyl-1H-imidazol-2-yl)methyl)-N-(pyridin-2-ylmethyl)prop-2-yn-1-amine (L2) have been used to synthesise a series of manganese(II) complexes for grafting onto appropriate solid supports. These ligands mimic the 2-His-1-carboxylate facial chelation present in the active site of the manganese-dependent dioxygenase (MndD), while the alkyne side function allows grafting of the ligand onto an azido-functionalised support using “click chemistry” methodologies. Such synthetic analogues of the MndD crystallise in the solid state as double halide or pseudohalide-bridged dinuclear manganese(II) complexes of the general formula [Mn2(μ-X)2X2L2] [L = L1 with X = Cl (1), Br (2), and N3 (3); L = L2 with X = N3 (4)]. Complexes 1–4 are characterised by a weak magnetic exchange interaction between the two high-spin MnII ions through the two X− bridges (J in the range of −0.059 to +5.30 cm−1, H = −J·SMn1·SMn2 with SMn1 = SMn2 = 5/2). A new magneto-structural correlation of superexchange bis(μ1,1-azido)dimanganese(II) complexes has been proposed using both structural parameters, the Mn–N–Mn bridging angle and the Mn–Nazido distance. In MeOH–EtOH solution the dimeric species are present together with few percents of mononuclear manganese(II) complexes as evidenced by electron paramagnetic resonance (EPR) spectroscopy. Grafting the complexes onto mesoporous silica of MCM-41 type stabilises both dimers and monomers in the nanopores of the solid.
Introduction
A natural evolution of bioinspired coordination chemistry is the immobilisation of metal complexes on solid supports where confinement can be created as in metalloproteins.1–3 Fixation on a support allows not only achieving site isolation but also controlling site nuclearity. Indeed, for monomeric sites, oligomerisation and degradation are often observed in solution with molecular bioinspired complexes. Therefore, it is important to develop new ligands with side functions allowing reactions that are orthogonal to complexation for fixation on a solid support. One possibility is to use the Huisgen azide–alkyne [2 + 3] cycloaddition reaction referred to as “click chemistry” by Sharpless and co-workers.4 Indeed, this efficient and versatile strategy, developed mainly for the synthesis of elaborate organic molecules (such as inhibitors for pharmaceutical applications), removes constraining considerations of protection/deprotection and cross-reactivity.5,6 This synthetic strategy has been applied to graft molecules onto various substrates such as organic polymers, carbon nanotubes, oxides and metals for the design of hybrid nanocomposite materials.7–9 In the case of silica-based supports, either azide or alkyne functions are grafted onto the solid support using the suitable organosiloxane molecules before carrying out the Huisgen cycloaddition reaction. In the case of immobilisation of a metal complex, it is preferred to have the alkyne function in the ligand and the azide in the tether to avoid complexation of azide to the metal ion. This modular approach has been used for example in the grafting of Co and V complexes with Schiff base ligands, or Pt and Pd organometallic complexes to develop heterogeneous catalysts.10,11
Among metalloproteins, iron and manganese oxygenases are particularly attractive because they can perform oxidation of organic substrates by activating molecular oxygen.12–19 In particular, catechol dioxygenases are ring-cleaving enzymes that oxidise catechol derivatives with a concomitant ring opening, which is a critical step in the aerobic degradation of aromatic compounds by bacteria.19 Therefore, these systems can be used as models to develop new materials for the degradation of aromatic chemicals. For instance, manganese-dependent dioxygenase (MndD) is known to catalyse the extradiol cleavage of catechol derivatives.15–18,20 The active site of this metalloprotein contains a mononuclear manganese centre coordinated to two histidines (His) and one glutamate (Glu) or one aspartate (Asp) in the facial position.21–23 This motif, called the 2-His-1-carboxylate facial triad, is observed in catechol dioxygenases as well as in other metalloproteins.15,24
In this work a new series of manganese complexes with two different biomimetic clickable ligands N,N′-bis((pyridin-2-yl)methyl)prop-2-yn-1-amine (L1) and N-((1-methyl-1H-imidazol-2-yl)methyl)-N-(pyridin-2-ylmethyl)prop-2-yn-1-amine (L2) is presented (Scheme 1). Both ligands can mimic the facial triad present in the active site of the MndD and possess an alkyne side function that allows for an efficient grafting onto a solid support using click chemistry.
|
| Scheme 1 Representation of ligands L1 and L2. Nitrogen atoms involved in the coordination of the metal ion are highlighted in red. | |
We report herein the crystal structures and the magnetic properties of four novel manganese(II) complexes of formulae [Mn2(L1)2Cl2(μ-Cl)2] (1), [Mn2(L1)2Br2(μ-Br)2] (2), [Mn2(L1)2(N3)2(μ1,1-N3)2]·2CH3OH (3), and [Mn2(L2)2(N3)2(μ1,1-N3)2] (4). The grafting is exemplified by the reaction of 1 with mesoporous silica (MCM-41 type) modified with azide functions.
Results and discussion
Synthesis of the ligands
The ligands L1 and L2 were synthesised according to experimental procedures reported in the literature. In the case of L1, two different synthetic methods were explored. The first one is a two-step protocol starting with the reduction with NaBH4 of the Schiff base resulting from the condensation of 2-picolylamine with 2-pyridinecarboxaldehyde which is followed by an electrophilic substitution with propargyl bromide to obtain the desired L1 ligand.25,26 The yield of the first step was 96% with a simple work-up whereas the purification by column chromatography on silica in the second step only yielded 11% of the product likely due to the less affinity of amino-pyridinic substrates to the acidic nature of the silica. Yet this latter should not be taken as a standard reaction yield as results found in the literature show average yields around 90%.27
The second method is a straightforward one-step protocol consisting of a double electrophilic substitution involving propargylamine and 2-picolyl chloride.28 The reaction time of 12 h was prolonged up to 5 days allowing us to retrieve L1 in a 90 to 96% yield, compared to a 32% yield for 12 h. Therefore this one-step protocol was the appropriate synthetic route to the L1 ligand (Scheme 2a).
|
| Scheme 2 (a) Synthesis of the ligand L1 and (b) synthesis of the ligand L2. | |
L2 is an original ligand that has been synthesized using an adapted version of the first method, i.e., condensation of an amine and an aldehyde, namely 2-picolylamine and 1-methyl-2-imidazolecarboxaldehyde, respectively, followed by a reduction29 and an electrophilic substitution by propargyl bromide (Scheme 2b). The first step provided the secondary amine in 96% yield. It is interesting to note the absence of undesired by-products in the second step, in contrast to the synthesis of L1 that required purification by column chromatography. In fact, re-dissolution in CH2Cl2 and filtration through KBr provided the pure ligand L2 in 80% yield.
Synthesis of the Mn(II) complexes
Complexes 1–4 were synthesized in MeOH using a stoichiometric amount of the ligand and metal salt (Scheme 3). For compounds 1 and 2 involving chloride and bromide counter-anions, respectively, the corresponding manganese salt was available and directly used for the reaction. In the case of 3 and 4, involving azide anions, manganese nitrate was reacted with the ligand and 4 equivalents of sodium azide were added to exchange the nitrate anion by the azide one. Except for 2, each compound precipitated as light brown powder in MeOH within 30 min. Those powders were then redissolved in a minimum amount of MeOH, while the solution containing 2 was used as it is. The crystals were grown using the same technique in all the cases, i.e., slow diffusion of diethyl ether in a methanolic solution of the compound to afford crystals within a couple of days. Apart from 3, all the crystals were stable in air at room temperature. Molecules of MeOH found in the structure of 3 were lost when left at room temperature, damaging the crystallinity of the solid.
|
| Scheme 3 Synthesis of the manganese(II) complexes. | |
Description of the structures
Complexes 1–4 are double halide or pseudohalide-bridged neutral dimers of Mn(II) and exhibit the same structural layout (Fig. 1). They differ in the nature of the donor groups from the organic ligand counterpart, i.e., amine and pyridines from L1 (1–3), or amine, pyridine and imidazole from L2 (4), as well as the coordinating anion composing the double bridge between the metal ions and completing the metal environment, i.e., chloride (1), bromide (2), or azide (3 and 4). Selected bond distances and angles for 1–4 are compiled in Table 1.
|
| Fig. 1 Structures of Mn(II) complexes with L1 and L2 ligands 1–4. | |
Table 1 Selected bond distances (Å) and angles (°)
|
1
|
2
|
3
|
4
|
1: X = Cl; 2: X = Br; 3 and 4: X = N3.
|
Mn(1)–N(1) |
2.280(4) |
2.264(2) |
2.255(2) |
2.296(1) |
Mn(1)–N(2) |
2.272(3) |
2.269(2) |
2.265(2) |
2.192(2) |
Mn(1)–N(3) |
2.388(3) |
2.389(2) |
2.384(2) |
2.466(2) |
Mn(1)–X(1)a |
2.515(2) |
2.6641(5) |
2.225(2) |
2.231(1) |
Mn(1)–X(2)a |
2.423(1) |
2.5740(5) |
2.153(2) |
2.131(2) |
Mn(1)–X(1)a |
2.574(1) |
2.7333(5) |
2.244(2) |
2.209(1) |
Mn⋯Mn |
3.827(1) |
4.0076(5) |
3.533(3) |
3.486(3) |
Mn–X(1)–Mna |
97.52(4) |
95.88(1) |
104.50(6) |
103.47(6) |
Within all complexes, the Mn(II) ions are located in a distorted N3X3 [X = Cl (1), Br (2) and N (3 and 4)] octahedral environment. In all the complexes, the Mn–N bond lengths from the tridentate ligands are similar and in good agreement with similar complexes involving a double bridge with double chloride,30–32 bromide33 and end-on azide34–37 bridges. It is important to note that the Mn–N bond length involving the central amine nitrogen atom of the ligand is usually ∼0.1 Å longer than the two external ones involving the pyridine and/or imidazole nitrogen atoms. In the case of 4, involving L2, one of the Mn–N bond lengths (N2) or the external nitrogen atoms of the ligand is shorter (∼0.1) and the Mn–N bond length for the central (N3) one is longer (∼0.1 Å) than those observed for complexes 1–3 involving L1. The environment of the metal ions is completed by three X atoms with two of them involved in the double bridge between the two Mn(II) ions. As expected, Mn–Cl bond lengths are shorter than the Mn–Br ones. Moreover, Mn–X bond lengths within the double bridge (X = Cl1, Br1) are longer (∼0.1 Å) than the terminal ones (X = Cl3, Br3).
The distortion of the octahedral environment of the metal ion is also exemplified by the distribution, far from the ideal values of 90 and 180°, of the X–Mn–X angles (X = N, Br and Cl) ranging from 69.72(5)° to 104.193(16)° and from 158.24(3)° to 163.59(4)° for 1, from 71.45(8)° to 101.689(15)° and from 159.85(5)° to 165.10(6)° for 2, from 72.86(5)° to 105.08(6)° and from 154.43(6)° to 163.57(6)° for 3, and from 69.79(4)° to 103.22(7)° and from 154.83(6)° to 161.98(5)° for 4.
In the crystal lattice of 1 and 2, structural packing is built by weak hydrogen bonding H⋯X (X = Cl and Br, respectively) interactions leading to a dense 3D network. In the case of 3, the co-crystallized methanol molecule, through the hydrogen atom of the alcoholic group, forms hydrogen bonds with the terminal nitrogen atom of the double end-on azido-bridge. Finally, for 3 and 4, the crystal packing, in both cases, is assumed to be formed by weak interactions as van der Waals interactions for example.
Magnetic properties
Fig. 2 shows the magnetic properties of 1–4 in the form of χMT versus T plots and M versus H plots, χM and M being the magnetic susceptibility and the magnetisation per two Mn(II) ions respectively, while T and H are the absolute temperature and the applied magnetic field, respectively.
|
| Fig. 2 Temperature dependence of χMT for 1 (top left), 2 (top right), 3 (bottom left) and 4 (bottom right). The solid line represents the best fit based on the parameters discussed in the text (Table 2). The inset shows the magnetization curve at 2.0 K and the solid line is the theoretical Brillouin curve for two magnetically independent spin sextuplets, S = 5/2. | |
At room temperature, χMT for 1 and 2 is ca. 8.75 cm3 mol−1 K. Whereas this value is expected for two magnetically isolated high-spin MnII ions (SMn = 5/2), the corresponding values for 3 and 4 are somewhat greater (ca. 9.5 cm3 mol−1 K). Upon cooling, χMT for 1 remains constant until 25.0 K and it further decreases to 7.70 cm3 mol−1 K at 2.0 K, suggesting the occurrence of a very weak antiferromagnetic interaction. In contrast, χMT for 2–4 continuously increases with the decrease of the temperature to reach maxima at 5.5 K (ca. 11.3 cm3 mol−1 K) for 2 and at 10 K (ca. 14.8 cm3 mol−1 K) for 3 and 4. After these maxima, χMT decreases to 7.5 (2), 13.7 (3) and 13.9 cm3 mol−1 K (4) at 2.0 K. The increase of χMT in the high temperature region for 2–4 is indicative of the occurrence of a ferromagnetic interaction between the paramagnetic Mn(II) ions, whereas the decrease at low temperatures can be attributed to weak intermolecular antiferromagnetic interactions and/or zero-field splitting of the S = 5 ground spin state. However, because of the large isotropic character of the six-coordinate high-spin Mn(II) ion, the zero-field splitting effects are expected to be negligible.
The expression of the magnetic susceptibility for a dimanganese(II) unit derived from the Van Vleck's equation (the spin Hamiltonian being defined as H = −JSMn1·SMn2) is given by eqn (1),38
| | (1) |
where
x =
J/
kT and
θ is the Weiss constant defined as
θ =
zJ′
S(
S + 1)/3
k with
zJ′ accounting for the magnetic interaction between the
z nearest dinuclear units. The other parameters have their usual meaning. The best-fit parameters obtained are listed in
Table 2.
Table 2 Best-fit parameters for 1–4 (see the text)
Compound |
g
|
J/cm−1 |
zJ′/cm−1 |
1
|
1.99(1) |
−0.059(1) |
0.0 |
2
|
1.99(1) |
+1.04(2) |
−0.20(1) |
3
|
2.01(1) |
+5.30(4) |
−0.060(2) |
4
|
2.02(1) |
+4.99(3) |
−0.052(2) |
As indicated above, the decrease of χMT at low temperatures for 2–4 could be alternatively interpreted by the presence of a zero-field splitting (D). Having this possibility in mind, the magnetic data for 2–4 were also analysed through the Hamiltonian of eqn (2) using VPMAG.39
| H = −JSMn1·SMn2 + D(S2z Mn1 + S2zMn2 + 35/6) | (2) |
The least-squares fit of the experimental data to eqn (2) gave values for the g and J parameters similar to those obtained through eqn (1) (Table 2), but the values for the D parameter [4.9 (2), 1.4 (3) and 1.1 cm−1 (4)] are too high to be considered real and they are meaningless. In fact, the reported D values for the high-spin d5 MnII ion in an octahedral environment are lower than 1 cm−1.40 So, the decrease of the χMT values has to be mainly attributed to intermolecular antiferromagnetic interactions.
Field dependence magnetisation plots of 1–4 at 2.0 K are shown in the inset of the corresponding plot (Fig. 2). The isothermal magnetisation data for 1 are well below the Brillouin curve for two magnetically isolated S = 5/2 Mn(II) ions (with no ZFS), while they are well above for 2–4, in agreement with the occurrence of antiferro- (1) or ferromagnetic (2–4) interactions between the Mn(II) ions.
The main magneto-structural parameters for a series of [MnII(μ-X)2MnII] (X = Cl or Br) dinuclear complexes which were the subject of previous studies are listed in Table 3. As far as we know, no theoretical magneto-structural correlation has been reported for this family of compounds. As one can see therein, no correlation seems to exist between the structural parameters (angles or distances) and the magnetic coupling parameter (J), this circumstance being most likely due to the low number of compounds, the small variation of the structural parameters and the experimental errors. However, there must exist a correlation between the nature and the magnitude of the magnetic exchange and the structural parameters, the value of the Mn–X–Mn angle being the most determinant one, as is known for other metal ions and bridging ligands.41 In fact, the experimental data from Table 3 predict a change from ferro- to antiferromagnetic behaviour at an angle of ca. 97° for the bridgehead chloro atom. The value of this crossover Mn–Cl–Mn angle is very close to that observed for the bis(μ-hydroxo)dicopper(II) complexes (ca. 97.5°).42 Compound 2 is the first example of a bis(μ-bromo)dimanganese(II) complex studied for its magnetic properties and so, we can only compare it with the chloro derivatives listed in Table 3.
Table 3 Selected magneto-structural parameters for bis(μ-X)dimanganese(II) complexes (X = Cl or Br)
Compounda |
d
Mn–Mn/Å |
d
Mn–Cl/Å |
Mn–X–Mn/° |
J/cm−1 |
Ref. |
Abbreviations: biz = 2,2′-biimidazoline; bpa = N,N′-bis(2-pyridylmethyl) ethylamine; mpbpa = N-(3-methoxypropyl)-N,N′-bis(pyridin-2-ylmethyl) amine; L1 = see text; t.w. = this work.
|
[Mn2(biz)2(μ-Cl)2]Cl2 |
3.74 |
2.57 |
93.5 |
+0.66 |
32
|
[Mn2(bpea)2Cl2(μ-Cl)2] |
3.79 |
2.48 |
95.7 |
+0.68 |
30
|
[Mn2(mpba)2Cl2(μ-Cl)2] |
3.9 |
2.50 |
96.4 |
+1.1 |
31
|
1
|
3.82 |
2.54 |
97.5 |
−0.06 |
t.w. |
2
|
4.00 |
2.69 |
95.9 |
+1.04 |
t.w. |
Concerning the bis(μ1,1-azido)dimanganese(II) complexes (3 and 4), an experimental relationship between the magnetic coupling constant (J) and the Mn–N–Mn bridging angle (θ), J (cm−1) = 0.552θ (deg) − 53.8, was proposed.36,43Table 4 shows the magneto-structural parameters for double end-on azido-bridged Mn(II) complexes. 3 and 4 follow roughly the above relationship and they are in good agreement with the fact that the value of the exchange coupling constant increases with the Mn–N–Mn bridging angle, which is consistent with theoretical predictions.41 A careful inspection of the data listed in Table 4 shows that the values of the coupling parameter, J, generally increase with an increase in the difference between the two Mn–N(bridging azide) bond distances (Δd in Table 4),36,43 which is an increase in the asymmetry of the azido bridging. In this sense, a better magneto-structural correlation is observed when we use both structural parameters (θ and Δd). Fig. 3 shows the values of J versus the corresponding values of (θ + 10Δd) from Table 4. The best linear fit gives the equation J (cm−1) = 0.553[θ (deg) + 10Δd (Å)] − 54.111, which is slightly better than J (cm−1) = 0.576θ (deg) − 54.040, where the influence of Δd has been neglected.
|
| Fig. 3 Plot of J versus (θ + 10Δd), θ being the average Mn–N–Mn angles and Δd being the average Mn–N (azido-bridge) bond distances (see the text), for double end-on azido-bridged Mn(II) complexes (see Table 3). The solid straight line represents the best linear fit to equation J = 0.553(θ + 10Δd) − 54.111. | |
Table 4 Selected magneto-structural parameters for bis(μ1,1-azido)dimanganese(II) complexesa
Compound |
Δd/Å |
θ (°) |
θ + 10Δd |
J/cm−1 |
Ref. |
Average values. Δd = d(Mn–Nazido) – d(Mn–N′azido). ttp = 4′-p-Tolyl-2,2′:6′,2′’-terpyridine, ttp-N3 = 4′-p-azidomethylphenyl-2,2′:6′,2′’-terpyridine, LA = [N,N-bis(pyridine-2-yl)benzylidene]ethane-1,2-diamine, LB = [N,N-bis(pyridine-2-yl)-benzylidene]propane-1,3-diamine, LC = [N,N-bis(pyridine-2-yl)benzylidene]butane-1,4-diamine, bpb2− = 1,2-bis(pyridine-2-carboxamido)benzenate, 2,2′-dpa = 2,2′-dipicolylamine, tptz = 2,4,6-tris(2-pyridyl)-1,3,5-triazine, pyz = pyrazine, 2-bzpy = 2-benzoylpyridine, LD = 2-(benzimidazol-2-yl)-N-(pyridin-2-ylmethyl)ethanamine.
|
[Mn2(ttp)2(N3)2(μ1,1-N3)2] |
0.236 |
103.45 |
105.81 |
4.92 |
36
|
[Mn2(ttp-N3)2(N3)2(μ1,1-N3)2] |
0.252 |
103.13 |
105.65 |
4.50 |
36
|
[Mn2(ttp-N3)2(N3)2(μ1,1-N3)2]2[Mn(ttp-N3)(N3)3] |
0.150 |
105.29 |
106.79 |
3.84 |
36
|
[Mn2(terpy)2(N3)2(μ1,1-N3)2]·2H2O |
0.090 |
104.60 |
105.50 |
4.86 |
44
|
[Mn2(LA)2(μ1,1-N3)2](ClO4)2 |
0.030 |
102.12 |
102.42 |
1.54 |
43
|
[Mn2(LB)2(μ1,1-N3)2](ClO4)2 |
0.072 |
104.29 |
105.01 |
4.09 |
43
|
[Mn2(LC)2(μ1,1-N3)2](ClO4)2 |
0.053 |
103.58 |
104.11 |
3.50 |
43
|
[Mn2(phen)4(μ1,1-N3)2][Co(bpb)(CN)2]2·H2O |
0.002 |
102.60 |
102.62 |
2.54 |
45
|
[Mn2(phen)4(μ1,1-N3)2][Cr(bpb)(CN)2]2·H2O |
0.003 |
102.55 |
102.58 |
2.20 |
45
|
[Mn2(phen)4(μ1,1-N3)2][Fe(bpb)(CN)2]2·H2O |
0.006 |
101.40 |
101.46 |
2.40 |
45
|
[Mn2(2,2′-dpa)2(N3)2(μ1,1-N3)2] |
0.059 |
103.11 |
103.70 |
2.24 |
34
|
[Mn(tptz)(μ1,1-N3)2]n |
0.002 |
106.16 |
106.18 |
4.06 |
46
|
[Mn(pyz)(μ1,1-N3)2] |
0.000 |
98.80 |
98.800 |
1.22 |
47
|
[Mn(2-bzpy)(μ1,1-N3)2]n |
0.032 |
100.50 |
100.82 |
0.80 |
48
|
[Mn2LD(N3)2(μ1,1-N3)2] |
0.202 |
100.38 |
102.40 |
2.62 |
37
|
3
|
0.019 |
104.50 |
104.69 |
5.30 |
t.w. |
4
|
0.020 |
103.96 |
104.16 |
4.99 |
t.w. |
EPR characterization of the complex in solution
The molecular complex 1 is conveniently dissolved in MeOH–EtOH solution. Such a solution exhibits at room temperature a 6 line EPR signal centered at g = 2.001 ± 0.001, typical of Mn(II). It is assigned to the hyperfine coupling between the electronic spin (S = 5/2) and the nuclear manganese spin (I = 5/2) for the allowed transitions (ΔmS = ±1, ΔmI = 0). Upon simulation, the hyperfine coupling constant A is 97 ± 1 G (Fig. S5†). At low temperatures, a pair of forbidden lines due to cross terms in the spin Hamiltonian lie between each of the main hyperfine lines (Fig. 4).49 A quantitative study was performed with complex 1 at room temperature in order to determine the proportion of monomeric and dimeric species present in the solution. The spin concentration was measured using manganese(II) perchlorate in methanolic solution at various concentrations for calibration. Accordingly, only 1–1.5% of this dimeric complex yields EPR active monomeric species in solution at room temperature.
|
| Fig. 4 EPR spectra of 1 dissolved in the mixture MeOH–EtOH 1:1 (v/v) at 116 K and MnL1@SiO2 at 298 K. Microwave frequency: 9.41 GHz, amplitude modulation: 1 G (top), 5 G (bottom), gain: 60 dB, power: 4 mW (top), 2 mW (bottom). | |
Grafting onto silica
The above solution was used to graft the manganese complex in the nanopores of a mesoporous silica. 2D hexagonal LUS silica (MCM-41 type) prepared using cetyltrimethylammonium tosylate as the surfactant was chosen as a support.50,51 It possesses a narrow pore size distribution of 3.8 ± 0.1 nm and a large mesopore volume of 0.78 ± 0.01 cm3 g−1. Then azide-functionalised N3–(CH2)3–Si– groups were introduced into the solid support using a molecular stencil patterning technique that allows an homogeneous distribution of the desired functions, which are separated by hydrophobic (CH3)3–Si– groups.3,52–54 The manganese complex 1 was covalently grafted by using click chemistry. As an illustrative example, the azide-functionalized silica (N3@SiO2) was reacted with 1 in a MeOH–MeCN mixture in the presence of the tris-(triphenylphosphine)copper(I) bromide catalyst55 to obtain the hybrid material MnL1@SiO2, with 2.5 wt% manganese. This complex loading corresponds to ∼80% yield for the click reaction. Note that the use of such a Cu(I) complex avoids the displacement of Mn(II) from the L1 ligand by Cu(I) during the grafting of the complex. Indeed, there are no traces of Cu(II) that would form under aerobic conditions, according to the EPR spectrum (Fig. 4). On the other hand, the signal reveals the presence of Mn(II) as in solution. Indeed, the proportion of EPR active species remains similar to that in solution, consistent with most of the species being still dimeric. In addition, the signal is broader than in solution both at room temperature and at 116 K. Therefore, this broadening is not due to dynamic effects but due to distribution of species on the surface. This gives evidence of the heterogeneity of the environment around the grafted species as usually observed in such hybrid materials.2
The hexagonal array of the internal pores of the material was unaltered all through the different steps of the synthesis, as shown from the X-ray diffraction patterns (Fig. 5). The decrease of pore volume from 0.78 cm3 g−1 down to 0.48 cm3 g−1 after grafting confirmed the presence of the metal complex inside the pores (ESI, Fig. S6†). Concomitantly, the specific surface area underwent a diminution from 990 m2 g−1 to 340 m2 g−1. This is consistent with partial pore filling due to internal molecular functionalization of the silica.
|
| Fig. 5 X-ray diffraction patterns (powder) of LUS (mesoporous SiO2 support), N3@SiO2 and MnL1@SiO2 materials. | |
Conclusions
A series of dinuclear manganese(II) complexes with two μ-X bridges (X = Cl, Br or N3) has been synthesised using two different clickable ligands. These ligands allow both coordination to a metal ion and also grafting onto an azide-functionalized support using the Huisgen alkyne–azide cycloaddition reaction. Within this series we present the first μ-Br bridged Mn(II) dinuclear complex for which a complete magnetic property study has been performed. It turned to be weakly ferromagnetic compared to the μ-Cl analogue, which is weakly antiferromagnetic. It is also noteworthy that a better magneto-structural correlation is observed when both structural parameters (θ and Δd) are considered for the bis(μ1,1-azido)dimanganese(II) complexes. Successful stabilisation of the complex mainly in its dimeric form has been achieved by grafting onto mesoporous silica. This kind of hybrid nanocomposite material, where confinement is at stake, could help by comparison to better understand the catalytic mechanism of MndD.16,23,56 The study of the catalytic properties of these silica-supported manganese(II) complexes is under progress. Alternatively, the alkyne function present in the ligand opens up other opportunities such as using these complexes as building blocks for the synthesis of metal–organic frameworks (MOFs).57
Experimental
Synthesis of the ligands
N,N′-Bis((pyridin-2-yl)methyl)prop-2-yn-1-amine ligand (L1).
The synthesis was based on a published protocol.28 A mixture of propargylamine (1.50 g, 27.3 mmol) and potassium carbonate (22.8 g, 163.8 mmol) was stirred in 140 mL of acetonitrile for 5 min. Then 2-picolyl chloride hydrochloride (9.84 g, 60.0 mmol) dissolved in 140 mL of acetonitrile was added. The resulting solution was stirred under reflux for 5 days. The solution was filtered and the filtrate was evaporated under reduced pressure. The resulting brown oil was dissolved in 100 mL of distilled water and extracted thrice with dichloromethane. The organic phases were gathered and dried over sodium sulphate. The solvent was finally evaporated to afford L1 in 94% yield. 1H NMR (CDCl3, 300 MHz): δ (ppm) 8.55 (ddd, J = 4.80, 1.80, 0.90 Hz, 2H), 7.64 (td, J = 7.50, 1.80 Hz, 2H), 7.50 (d, J = 7.80 Hz, 2H), 7.15 (ddd, J = 7.50, 4.80, 1.20 Hz, 2H), 3.91 (s, 4H), 3.41 (d, J = 2.40 Hz, 2H), 2.29 (t, J = 2.40 Hz, 1H). 13C NMR (300 MHz, CDCl3): δ (ppm) 158.76, 149.26, 136.47, 123.14, 122.10, 78.32, 73.62, 59.44, 42.54. IR (KBr): 3294 (w), 3062 (w), 3011 (w), 2921 (w), 2839 (w), 2095 (m, CC) cm−1.
N-((1-Methyl-1H-imidazol-2-yl)methyl)-N-(pyridin-2-ylmethyl)prop-2-yn-1-amine (L2).
This ligand was synthesized in two steps.
N-(1-Methyl-1H-imidazol-2-ylmethyl)pyrid-2-ylmethylamine29.
2-Picolylamine (2.45 g, 22.7 mmol) in 25 mL of methanol was added dropwise to a solution of 1-methyl-2-imidazolecarboxaldehyde (2.5 g, 22.7 mmol) in 50 mL of methanol. The resulting solution was stirred for 3 h at room temperature. Sodium borohydride (0.86 g, 22.7 mmol) was added portionwise and the solution was further stirred for two more hours at room temperature. The solvent was evaporated under reduced pressure and the orange oil thus obtained was redissolved in a mixture of water–methanol (25 mL/50 mL), before being extracted thrice with 50 mL of dichloromethane. The combined organic phases were washed with 50 mL of water and dried over sodium sulphate. The solvent was finally removed to obtain the product as an orange oil in 96% yield. 1H NMR (CDCl3, 300 MHz): δ (ppm) 8.54 (ddd, J = 4.80, 1.80, 0.90 Hz, 1H), 7.63 (td, J = 7.50, 1.80 Hz, 1H), 7.31 (d, J = 7.80 Hz, 1H), 7.15 (ddd, J = 7.50, 4.80, 1.20 Hz, 1H), 6.92 (d, J = 1.20 Hz, 1H), 6.80 (d, J = 1.20 Hz, 1H), 3.93 (s, 2H), 3.89 (s, 2H), 3.66 (s, 3H).
Synthesis of L2.
N-(1-Methyl-1H-imidazol-2-ylmethyl)pyrid-2-ylmethylamine (3 g, 14.8 mmol) and potassium carbonate (8.18 g, 59.2 mmol) were dissolved in 40 mL of tetrahydrofuran. Then propargyl bromide was added dropwise, and the resulting solution was heated at 50 °C for 18 h. The solvent was removed under reduced pressure, and the brown oil thus obtained was dissolved in dichloromethane before being passed over several pads of potassium carbonate until disappearance of the hydrobromic acid. The dichloromethane was removed under reduced pressure and the ligand L2 was obtained in an 80% yield. 1H NMR (CDCl3, 300 MHz): δ (ppm) 8.51 (ddd, J = 4.80, 1.80, 0.90 Hz, 1H), 7.60 (td, J = 7.50, 1.80 Hz, 1H), 7.32 (d, J = 7.80 Hz, 1H), 7.12 (ddd, J = 7.50, 4.80, 1.20 Hz, 1H), 6.88 (d, J = 1.20 Hz, 1H), 6.76 (d, J = 1.20 Hz, 1H), 3.80 (s, 2H), 3.79 (s, 2H), 3.58 (s, 3H), 3.32 (d, J = 2.40 Hz, 2H), 2.27 (t, J = 2.40 Hz, 1H). 13C NMR (300 MHz, CDCl3): δ (ppm) 158.28, 149.26, 144.59, 136.45, 127.27, 123.44, 122.21, 121.58, 78.27, 73.74, 59.29, 49.54, 42.44, 32.84. IR (KBr): 3010 (w), 2926 (w, br), 2839 (w), 2100 (m, CC) cm−1.
Synthesis of the manganese(II) complexes
[Mn2(L1)2(Cl)2(μ-Cl)2] (1).
A solution of L1 (47 mg, 0.2 mmol) in 2 mL of methanol was slowly added to a solution of MnCl2 (40 mg, 0.2 mmol) in 2 mL of methanol. The solution was stirred for 1 h, and then the solid was filtered and washed with methanol to obtain 38 mg of the complex in 52% yield. This powder was redissolved in a minimum amount of methanol, and pale yellow crystals of 1 were obtained by slow diffusion of diethylether into this solution.
[Mn2(L1)2(Br)2(μ-Br)2] (2).
A solution of L1 (47 mg, 0.2 mmol) in 2 mL of methanol was slowly added to a solution of MnBr2·4H2O (57 mg, 0.2 mmol) in 2 mL of methanol. This solution was kept under stirring for 1 h. Brown crystals of 2 were obtained by slow diffusion of diethylether into the latter solution.
[Mn2(L1)2(N3)2(μ-N3)2]·2CH3OH (3).
A solution of L1 (24 mg, 0.1 mmol) in 2 mL of methanol was slowly added to a solution of Mn(NO3)2·4H2O (25 mg, 0.1 mmol) in 2 mL of methanol. The solution was stirred for 30 min, and then a solution of NaN3 (26 mg, 0.4 mmol) in 3 mL of methanol was added. The mixture was further stirred for 1 h, and the solid thus formed was filtered and washed with methanol. The solid was redissolved in methanol, and slow diffusion of diethylether into that solution provided crystals suitable for X-ray diffraction.
[Mn2(L2)2(N3)2(μ-N3)2] (4).
The synthesis is similar to the synthesis of 3, the only difference being that L2 (24 mg, 0.1 mmol) was used instead of L1. Suitable crystals for X-ray diffraction were obtained following the same diffusion protocol.
Synthesis of MnL1@SiO2
The manganese complex was grafted onto LUS mesoporous silica where azide functions were previously incorporated using the so-called molecular stencil pattering technique described elsewhere.53
Mesoporous silica LUS.
A solution of cetyltrimethylammonium tosylate (CTATos) (1.96 g, 4.3 mmol) in distilled water (71 mL) was stirred at 60 °C for 1 h. In the meantime, a sodium silicate solution (49 mL) was also stirred at 60 °C for 1 h. The silicate solution was added to the surfactant one by pouring it slowly on the edge of the recipient. After a vigorous shaking by hand, the resulting white mixture was placed in two autoclaves and heated in a microwave oven for 10 min at 180 °C. The autoclaves were cooled in an ice bath for 10 min before filtration and washing with distilled water (about 100 mL). The white solid obtained was dried at 80 °C to obtain 3.1 to 3.4 g of LUS. Elemental analyses: Si (23.63%), C (30.91%), H (6.31%), N (1.72%), S (0.20%).
N3@SiO2.
LUS silica was functionalized with trimethylsilyl functions (TMS) using a reported protocol to afford TMS@SiO2.53 Then, TMS@LUS (500 mg) was pre-treated at 130 °C under argon for 2 h, and at 130 °C under vacuum for 2 more hours. After cooling under argon down to room temperature, a solution of 3-azidopropyl triethoxysilane (371 mg, 1.5 mmol) dissolved in 5 mL of dry toluene was added. The suspension was stirred for 1 h, 10 mL of toluene was added, and the mixture was stirred at 80 °C for 18 h. After filtration and washing with 20 mL of toluene, 20 mL of EtOH 70% and 20 mL of acetone, the solid was finally dried overnight at 80 °C. Elemental analysis (wt%): C: 5.18%, H: 1.80%, N: 2.06%.
MnL1@SiO2.
N3@SiO2 (300 mg) was added to the mixture MeOH–MeCN (60 mL/20 mL) and stirred. After 10 min, complex 1 (176 mg, 0.5 mmol) was added and the suspension was stirred for 1 h, before addition of CuBr(PPh3)3 (93 mg, 0.10 mmol). Then the mixture was stirred at 60 °C for 6 days before filtration. The pale brown solid was washed with 200 mL of MeOH to eliminate any catalyst and unreacted species left, and dried overnight at 80 °C. Elemental analysis (wt%): C: 6.42%, H: 1.75%, N: 1.44%, Mn: 2.43%, Cl: 0.74%.
Crystal structure determination and refinement
Single crystal X-ray diffraction data for 2–3 were collected at 293(2) K on a Bruker APEX II diffractometer using graphite-monochromated Mo-Kα radiation while data for 1 and 4 were collected and treated on a Gemini Oxford Diffractometer at 150 K and the related analysis software.58 Data reduction for 2–3 were performed with the SMART and SAINT software.59 The structures were solved by direct methods using the SHELXS-97 program,60 and refined on F2s by full-matrix least-squares with the SHELXL-97 program included in the WINGX software package.60,61 Absorption correction was applied using SADABS.62 For complexes 1 and 4, an absorption correction based on the crystal faces was applied to the datasets (analytical).63 Structures of 1 and 4 were solved by direct methods combined with Fourier difference syntheses and refined against F using reflections with [I/σ(I) > 3] using the CRYSTALS program.64 All non-hydrogen atoms were refined using anisotropic terms. The hydrogen atoms were placed at the calculated positions and refined with isotropic parameters as riding atoms. The hydrogen atoms for the co-crystallized methanol molecules were located from difference maps for complex 3. The final geometrical calculations and the graphical manipulations were carried out with PARST95,65 PLATON,66 (for complexes 2–4) and DIAMOND67 programs.
Crystal data, refinement results, atomic coordinates, selected bond lengths and bond angles for 1–4 are summarized in Tables S1–S12.†
Physical characterization
Infrared spectra were recorded on KBr pellets using a Mattson 3000 IRTF spectrometer. Nitrogen sorption isotherms at 77 K were determined with a volume device Belsorp Max on solids that were dried at 80 °C under vacuum overnight. Low angle X-ray powder diffraction (XRD) experiments were carried out using a Brucker (Siemens) D5005 diffractometer with Cu Kα monochromatic radiation. Variable-temperature magnetic susceptibility measurements were made using a Quantum Design SQUID susceptometer, using an applied field of 1000 G. Diamagnetic corrections of the constituent atoms were estimated from Pascal constants. EPR spectra were recorded using a Brucker Elexsys e500 X-band (9.4 GHz) spectrometer with a standard cavity. The EPR calibration was performed using manganese(II) perchlorate as the spin reference in the same range of concentrations as for the samples. The spin quantification was performed by double integration of the signal. The simulated spectra were calculated using the EasySpin toolbox from Matlab.
Acknowledgements
L. Khrouz is greatly acknowledged for recording and analysing the EPR spectra. J. C. thanks the French “Ministère de l'enseignement, de la recherche et de la technologie” (MERT) for a PhD fellowship, and the C-MIRA program of Rhône-Alpes region in France for financial support to the collaboration between the Universitat de València (Spain) and the Ecole Normale Supérieure de Lyon (France). The Spanish work was supported by the MICINN (Spain) (Project CTQ2010-15364) and the Generalitat Valenciana (Spain) (Projects PROMETEO/2009/108, and ISIC/2012/002). A part of this work was supported by the Fundo Europeu de Desenvolvimento Regional–QREN–Compete (Project PTDC/FIS/102284/2008) and the Fundação para a Ciência e Tecnologia (Project PEst-C/FIS/UI0036/2011).
Notes and references
- T. J. Terry and T. D. P. Stack, J. Am. Chem. Soc., 2008, 130, 4945–4953 CrossRef CAS PubMed.
- S. Abry, A. Thibon, B. Albela, P. Delichère, F. Banse and L. Bonneviot, New J. Chem., 2009, 33, 484–496 RSC.
- S. Calmettes, B. Albela, O. Hamelin, S. Menage, F. Miomandre and L. Bonneviot, New J. Chem., 2008, 32, 727–737 RSC.
- H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem., Int. Ed., 2001, 40, 2004–2021 CrossRef CAS.
- H. C. Kolb and K. B. Sharpless, Drug Discovery Today, 2003, 8, 1128–1137 CrossRef CAS.
- J. E. Moses and A. D. Moorhouse, Chem. Soc. Rev., 2007, 36, 1249–1262 RSC.
- L. Nebhani and C. Barner-Kowollik, Adv. Mater., 2009, 21, 3442–3468 CrossRef CAS.
- F. Santoyo-Gonzalez and F. Hernandez-Mateo, Chem. Soc. Rev., 2009, 38, 3449–3462 RSC.
- C. Chu and R. Liu, Chem. Soc. Rev., 2011, 40, 2177–2188 RSC.
- B. S. Rana, S. L. Jain, B. Singh, A. Bhaumik, B. Sain and A. K. Sinha, Dalton Trans., 2010, 39, 7760–7767 RSC.
- S. L. Jain, B. S. Rana, B. Singh, A. K. Sinha, A. Bhaumik, M. Nandi and B. Sain, Green Chem., 2010, 12, 374–377 RSC.
- E. A. Lewis and W. B. Tolman, Chem. Rev., 2004, 104, 1047–1076 CrossRef CAS PubMed.
- L. M. Mirica, X. Ottenwaelder and T. D. P. Stack, Chem. Rev., 2004, 104, 1013–1045 CrossRef CAS PubMed.
- E. I. Solomon, U. M. Sundaram and T. E. Machonkin, Chem. Rev., 1996, 96, 2563–2605 CrossRef CAS PubMed.
- P. C. A. Bruijnincx, G. van Koten and R. J. M. K. Gebbink, Chem. Soc. Rev., 2008, 37, 2716–2744 RSC.
- J. P. Emerson, M. L. Wagner, M. F. Reynolds, L. Que, M. J. Sadowsky and L. P. Wackett, J. Biol. Inorg. Chem., 2005, 10, 751–760 CrossRef CAS PubMed.
- T. D. H. Bugg and S. Ramaswamy, Curr. Opin. Chem. Biol., 2008, 12, 134–140 CrossRef CAS PubMed.
- L. Que and M. F. Reynolds, Met. Ions Biol. Syst., 2000, 37, 505–525 CAS.
- F. H. Vaillancourt, J. T. Bolin and L. D. Eltis, Crit. Rev. Biochem. Mol. Biol., 2006, 41, 241–267 CrossRef CAS PubMed.
- A. K. Whiting, Y. R. Boldt, M. P. Hendrich, L. P. Wackett and L. Que, Biochemistry, 1996, 35, 160–170 CrossRef CAS PubMed.
- M. W. Vetting, L. P. Wackett, L. Que, J. D. Lipscomb and D. H. Ohlendorf, J. Bacteriol., 2004, 186, 1945–1958 CrossRef CAS PubMed.
- V. Georgiev, T. Borowski and P. E. M. Siegbahn, J. Biol. Inorg. Chem., 2006, 11, 571–585 CrossRef CAS PubMed.
- J. P. Emerson, E. G. Kovaleva, E. R. Farquhar, J. D. Lipscomb and L. Que, Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 7347–7352 CrossRef CAS PubMed.
- K. D. Koehntop, J. P. Emerson and L. Que, J. Biol. Inorg. Chem., 2005, 10, 87–93 CrossRef CAS PubMed.
- M. J. Carney, N. J. Robertson, J. A. Halfen, L. N. Zakharov and A. L. Rheingold, Organometallics, 2004, 23, 6184–6190 CrossRef CAS.
- D. E. Bergbreiter, P. N. Hamilton and N. M. Koshti, J. Am. Chem. Soc., 2007, 129, 10666–10667 CrossRef CAS PubMed.
- S. Huang, R. J. Clark and L. Zhu, Org. Lett., 2007, 9, 4999–5002 CrossRef CAS PubMed.
- J. Rosenthal and S. J. Lippard, J. Am. Chem. Soc., 2010, 132, 5536–5537 CrossRef CAS PubMed.
- T. Dhanalakshmi, E. Suresh and M. Palaniandavar, Dalton Trans., 2009, 8317–8328 RSC.
- I. Romero, M. N. Collomb, A. Deronzier, A. Llobet, E. Perret, J. Pecaut, L. Le Pape and J. M. Latour, Eur. J. Inorg. Chem., 2001, 69–72 CrossRef CAS.
- J. Z. Wu, E. Bouwman, A. M. Mills, A. L. Spek and J. Reedijk, Inorg. Chim. Acta, 2004, 357, 2694–2702 CrossRef CAS PubMed.
- G. A. van Albada, A. Mohamadou, W. L. Driessen, R. de Gelder, S. Tanase and J. Reedijk, Polyhedron, 2004, 23, 2387–2391 CrossRef CAS PubMed.
- O. Seewald, U. Florke, G. Henkel and T. Seshadri, Acta Crystallogr., Sect. E: Struct. Rep. Online, 2005, 61, m1948–m1950 CAS.
- C. M. Liu, S. Gao, D. Q. Zhang, Z. L. Liu and D. B. Zhu, Inorg. Chim. Acta, 2005, 358, 834–838 CrossRef CAS PubMed.
- J. Qian, W. Gu, S. P. Yan, D. Z. Liao and P. Cheng, Acta Crystallogr., Sect. E: Struct. Rep. Online, 2007, 63, m687–m688 CAS.
- M. M. Yu, Z. H. Ni, C. C. Zhao, A. L. Cui and H. Z. Kou, Eur. J. Inorg. Chem., 2007, 5670–5676 CrossRef CAS.
- H. Y. Wu, H. Q. An, B. L. Zhu, S. R. Wang, S. M. Zhang, S. H. Wu and W. P. Huang, Inorg. Chem. Commun., 2007, 10, 1132–1135 CrossRef CAS PubMed.
-
O. Kahn, Molecular Magnetism, Wiley-VCH, 1993 Search PubMed.
-
J. Cano, VPMAG package, University of Valencia, Valencia, Spain, 2003 Search PubMed.
-
(a) R. Herchel, R. Boca, M. Gembicky, K. Falk, H. Fuess, W. Haase and I. Svoboda, Inorg. Chem., 2007, 46, 1544 CrossRef CAS PubMed;
(b) R. Boca, Coord. Chem. Rev., 2004, 248, 757 CrossRef CAS PubMed.
- E. Ruiz, J. Cano, S. Alvarez and P. Alemany, J. Am. Chem. Soc., 1998, 120, 11122–11129 CrossRef CAS.
- V. H. Crawford, H. W. Richardson, J. R. Wasson, D. J. Hodgson and W. E. Hatfield, Inorg. Chem., 1976, 15, 2107–2110 CrossRef CAS.
- T. K. Karmakar, B. K. Ghosh, A. Usman, H. K. Fun, E. Riviere, T. Mallah, G. Aromi and S. K. Chandra, Inorg. Chem., 2005, 44, 2391–2399 CrossRef CAS PubMed.
- R. Cortes, J. L. Pizarro, L. Lezama, M. I. Arriortua and T. Rojo, Inorg. Chem., 1994, 33, 2697–2700 CrossRef CAS.
- Z. H. Ni, H. Z. Kou, L. Zheng, Y. H. Zhao, L. F. Zhang, R. J. Wang, A. L. Cui and O. Sato, Inorg. Chem., 2005, 44, 4728–4736 CrossRef CAS PubMed.
- A. Das, G. M. Rosair, M. S. El Fallah, J. Ribas and S. Mitra, Inorg. Chem., 2006, 45, 3301–3306 CrossRef CAS PubMed.
- J. L. Manson, A. M. Arif and J. S. Miller, Chem. Commun., 1999, 1479–1480 RSC.
- M. A. M. Abu-Youssef, A. Escuer, D. Gatteschi, M. A. S. Goher, F. A. Mautner and R. Vicente, Inorg. Chem., 1999, 38, 5716–5723 CrossRef CAS.
- B. Bleaney and R. S. Rubins, Proc. Phys. Soc., 1961, 77, 103–112 CrossRef CAS.
- J. S. Beck, J. C. Vartuli, W. J. Roth, M. E. Leonowicz, C. T. Kresge, K. D. Schmitt, C. T. W. Chu, D. H. Olson, E. W. Sheppard, S. B. McCullen, J. B. Higgins and J. L. Schlenker, J. Am. Chem. Soc., 1992, 114, 10834–10843 CrossRef CAS.
-
P. Reinert, B. Garcia, C. Morin, A. Badiei, P. Perriat, O. Tillement and L. Bonneviot, in Nanotechnology in Mesostructured Materials, Elsevier Science Bv, Amsterdam, 2003, vol. 146, pp. 133–136 Search PubMed.
- S. Abry, B. Albela and L. Bonneviot, C. R. Chim., 2005, 8, 741–752 CrossRef CAS PubMed.
- A. Badiei, L. Bonneviot, N. Crowther and G. M. Ziarani, J. Organomet. Chem., 2006, 691, 5911–5919 CrossRef CAS PubMed.
- K. Zhang, B. Albela, M. Y. He, Y. M. Wang and L. Bonneviot, Phys. Chem. Chem. Phys., 2009, 11, 2912–2921 RSC.
- K. Buerglova, N. Moitra, J. Hodacova, X. Cattoen and M. W. C. Man, J. Org. Chem., 2011, 76, 7326–7333 CrossRef PubMed.
- V. Georgiev, T. Borowski, M. R. A. Blomberg and P. E. M. Siegbahn, J. Biol. Inorg. Chem., 2008, 13, 929–940 CrossRef CAS PubMed.
- M. Savonnet, E. Kockrick, A. Camarata, D. Bazer-Bachi, N. Bats, V. Lecocq, C. Pinel and D. Farrusseng, New J. Chem., 2011, 35, 1892–1897 RSC.
-
CrysAlisPro, v. 1.171.33.46, Oxford Diffraction Ltd, 2009 Search PubMed.
-
Bruker, SMART and SAINT, Bruker AXS Inc., Madison, Wisconsin, USA, 2003 Search PubMed.
-
G. M. Scheldrick, SHEKXL-97 and SHELXS-97, University of Göttingen, Germany, 1998 Search PubMed.
- L. J. Farrugia, J. Appl. Crystallogr., 2012, 45, 849–854 CrossRef CAS.
-
G. M. Sheldrick, SADBAS, University of Göttingen, Germany, 2003 Search PubMed.
- J. Der Meulen and H. Tompa, Acta Crystallogr., 1965, 19, 1014–1018 CrossRef.
-
D. J. Watkin, C. K. Prout, J. R. Carruthers, P. W. Betteridge and R. I. Cooper, CRYSTALS Issue 11, Chemical Crystallography Laboratory, University of Oxford, Oxford, UK, 1999 Search PubMed.
- M. Nardelli, J. Appl. Crystallogr., 1995, 28, 659–659 CrossRef CAS.
- A. L. Spek, Acta Crystallogr. Sect. A: Fundam. Crystallogr., 1990, 46, c34 Search PubMed.
-
K. Brandenburg and H. Putz, DIAMOND 2.1d, Crystal Impact GbR, Bonn, Germany, 2000 Search PubMed.
Footnote |
† Electronic supplementary information (ESI) available: Crystallographic details of the complexes, crystal packing figures of 1–4, EPR simulation of 1 and N2 sorption isotherms of the porous materials. CCDC 905065, 911104–911106 for 1–4. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c3dt53636j |
|
This journal is © The Royal Society of Chemistry 2014 |
Click here to see how this site uses Cookies. View our privacy policy here.